🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
The purpose of this study is to evaluate the pharmacokinetics, safety, tole...
Status
Active Not Recruiting
Location
Children's Hospital of Orange County
Start Date
2022-06-21
Trial ID
NCT05422222
Treatments Being Tested
The purpose of this study is to evaluate the effect of multiple doses of va...
Status
Completed
Location
Altasciences - Kansas City
Start Date
2026-01-12
Trial ID
NCT07349394
Treatments Being Tested
This study will evaluate the efficacy and safety of CTP-656 in patients wit...
Status
Terminated
Location
University of Southern California
Start Date
2016-12
Trial ID
NCT02971839
The purpose of this study is to evaluate the relative bioavailability, food...
Status
Completed
Location
Celerion, Inc.
Start Date
2024-03-13
Trial ID
NCT06299709
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK) and safe...
Status
Completed
Location
Clinical Pharmacology of Miami, LLC
Start Date
2022-07-22
Trial ID
NCT05437120
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, pharmacodyna...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2019-04-17
Trial ID
NCT03911713
The purpose of this study is to evaluate the long-term safety, tolerability...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-11-08
Trial ID
NCT05444257
Treatments Being Tested
The purpose of this study is to evaluate the relative bioavailability of a ...
Status
Completed
Location
ICON Salt Lake City
Start Date
2022-09-15
Trial ID
NCT05535959
Treatments Being Tested
The purpose of the study is to evaluate safety, tolerability, and pharmacok...
Status
Completed
Location
Joe DiMaggio Cycstic Fibrosis & Pulmonary Center
Start Date
2023-12-12
Trial ID
NCT06154447
Treatments Being Tested